Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 155.00
+1.00 (0.65%)
Dec 31, 2025, 2:36 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 240.39 billion as of December 31, 2025. Its market cap has increased by 167.35% in one year.
Market Cap
240.39B
Enterprise Value
233.88B
Revenue
34.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
155.00
Market Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 240.39B, an increase of 2,920.57%. That is a compound annual growth rate of 209.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 240.39B | 154.74% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 174.75B |
| Lotus Pharmaceutical | 73.63B |
| Heron Neutron Medical | 70.42B |
| Bora Pharmaceuticals Co., LTD. | 60.90B |
| Lin BioScience | 33.13B |
| Lumosa Therapeutics | 31.84B |
| Center Laboratories | 30.94B |
| Oneness Biotech | 26.84B |